We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+13.77%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$6.41B
AUM Growth
-$838M
(-12%)
Cap. Flow
-$1.23B
Cap. Flow
% of AUM
-19.2%
Top 10 Holdings %
Top 10 Hldgs %
13.63%
Holding
1,903
New
444
Increased
263
Reduced
318
Closed
672
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PMT
PennyMac Mortgage Investment
PMT
|
+$19.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$17M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$13.6M |
| 4 |
EVA
Enviva Inc.
EVA
|
+$8.45M |
| 5 |
APA Corp
APA
|
+$7.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Petrobras
PBR
|
+$43.9M |
| 2 |
CVR Partners
UAN
|
+$26M |
| 3 |
Zoom
ZM
|
+$12.1M |
| 4 |
EQT Corp
EQT
|
+$12M |
| 5 |
PING
Ping Identity Holding Corp.
PING
|
+$6.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.55% |
| 2 | Energy | 1.26% |
| 3 | Technology | 1.15% |
| 4 | Consumer Discretionary | 0.9% |
| 5 | Materials | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
CALL
Globalstar
GSAT
$10.7B
| $266K | ﹤0.01% |
13,333
| – | – |
|
|
PRVB
1027
CALL
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $264K | ﹤0.01% |
25,000
| – | – |
|
1028
Caesars Entertainment
CZR
$6.06B
| $261K | ﹤0.01% |
6,275
-30,175
| -83% | -$1.34M |
|
1029
United Airlines
UAL
$39.4B
| $257K | ﹤0.01% |
+6,820
| New | +$277K |
|
1030
CALL
NuScale Power
SMR
$2.91B
| $257K | ﹤0.01% |
+25,000
| New | +$277K |
|
1031
Mattel
MAT
$4.38B
| $256K | ﹤0.01% |
14,375
+5,000
| +53% | +$90.7K |
|
1032
Ultragenyx Pharmaceutical
RARE
$2.45B
| $255K | ﹤0.01% |
5,500
-46,300
| -89% | -$1.82M |
|
1033
Eldorado Gold
EGO
$7.87B
| $252K | ﹤0.01% |
30,200
-235
| -0.8% | -$1.67K |
|
1034
General Motors
GM
$80.4B
| $249K | ﹤0.01% |
7,403
-97
| -1% | -$3.58K |
|
1035
Seagate
STX
$194B
| $247K | ﹤0.01% |
+4,697
| New | +$250K |
|
1036
PUT
Beyond Meat
BYND
$292M
| $246K | ﹤0.01% |
20,000
| – | – |
|
|
ROIVW
1037
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
| $246K | ﹤0.01% |
126,856
| – | – |
|
1038
Lockheed Martin
LMT
$134B
| $243K | ﹤0.01% |
+500
| New | +$232K |
|
1039
Walt Disney
DIS
$167B
| $239K | ﹤0.01% |
2,756
-6,944
| -72% | -$664K |
|
1040
CALL
Twist Bioscience
TWST
$5.7B
| $238K | ﹤0.01% |
+10,000
| New | +$290K |
|
1041
CALL
Arbutus Biopharma
ABUS
$857M
| $236K | ﹤0.01% |
101,100
+1,100
| +1% | +$2.63K |
|
|
MRSN
1042
CALL
DELISTED
Mersana Therapeutics
MRSN
| $234K | ﹤0.01% |
+1,600
| New | +$270K |
|
|
MRSN
1043
PUT
DELISTED
Mersana Therapeutics
MRSN
| $234K | ﹤0.01% |
+1,600
| New | +$270K |
|
1044
Starwood Property Trust
STWD
$5.92B
| $234K | ﹤0.01% |
+12,746
| New | +$254K |
|
|
1045
PUT
Arbutus Biopharma
ABUS
$857M
| $233K | ﹤0.01% |
100,000
| – | – |
|
|
CFLT
1046
DELISTED
Confluent
CFLT
| $232K | ﹤0.01% |
+10,443
| New | +$242K |
|
|
ME
1047
DELISTED
23andMe Holding Co
ME
| $230K | ﹤0.01% |
5,331
+1,331
| +33% | +$77.5K |
|
1048
Celldex Therapeutics
CLDX
$2.99B
| $223K | ﹤0.01% |
5,000
-5,944
| -54% | -$212K |
|
1049
Tenet Healthcare
THC
$20.5B
| $220K | ﹤0.01% |
4,500
+3,782
| +527% | +$175K |
|
1050
Clarus
CLAR
$123M
| $216K | ﹤0.01% |
27,500
+27,200
| +9,067% | +$265K |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q4 2022 Portfolio in Review
As of Q4 2022, Caption Management held 1,903 positions worth $6.41B, down 12% from $7.25B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Caption Management withdrew a net $1.23B in Q4 2022, closing 672 positions and reducing 318 holdings. Its most notable exit was Petrobras, an estimated $43.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 2.5% of assets, up from 1.5% a quarter earlier, followed by Energy and Technology.
Against the trend, Caption Management opened a new position in PennyMac Mortgage Investment worth $17.9M.
- Caption Management's largest Q4 2022 buy was PennyMac Mortgage Investment: 1,448,050 shares worth $17.9M.
- Caption Management added most to State Street SPDR S&P Biotech ETF in Q4 2022, an estimated $13.6M increase.
- Caption Management's biggest Q4 2022 reduction was EQT Corp, cutting an estimated $12M.
- Caption Management fully exited Petrobras in Q4 2022, selling an estimated $43.9M.
- Caption Management's ten largest holdings make up 14% of its $6.41B portfolio in Q4 2022.
- Caption Management opened 444 new positions and closed 672 in Q4 2022.
- Caption Management's portfolio value fell 12% quarter-over-quarter to $6.41B.
Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.